Covidien PLC (COV) financial statements (2021 and earlier)

Company profile

Business Address 20 ON HATCH
DUBLIN, DUBLIN 2
State of Incorp.
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
3/31/2014
Q2
12/31/2013
Q1
9/30/2013
Q4
6/30/2013
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,8181,5671,2281,1781,5811,8682,119
Cash and cash equivalents1,8181,5671,2281,1781,5811,8682,119
Receivables1,4511,5321,5581,5521,6021,5261,562
Inventory, net of allowances, customer advances and progress billings1,4221,4081,4281,4191,3541,3521,346
Inventory1,4221,4081,4281,4191,3541,3521,346
Derivative instruments and hedges, assets1167023810  
Income taxes receivable55 62 
Other undisclosed current assets7808228431,2221,2931,0591,185
Total current assets:5,5875,4545,0805,3795,8405,8676,212
Noncurrent Assets
Property, plant and equipment1,9842,0242,0592,0332,0012,0121,967
Intangible assets, net (including goodwill)12,03212,13311,92711,97510,67410,85910,884
Goodwill8,8238,8518,7528,7528,1258,1728,156
Intangible assets, net (excluding goodwill)3,2093,2823,1753,2232,5492,6872,728
Other noncurrent assets740810812745737805795
Other undisclosed noncurrent assets272280345375367375357
Total noncurrent assets:15,02815,24715,14315,12813,77914,05114,003
TOTAL ASSETS:20,61520,70120,22320,50719,61919,91820,215
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4731,1995081,1659861,6161,156
Accounts payable473501501511493501469
Employee-related liabilities 495   426 
Taxes payable 2037654493689687
Debt1,0101,0091,007661113
Derivative instruments and hedges, liabilities15881417  
Deferred tax liabilities 12   5 
Other liabilities1,4321,7181,2901,4721,2331,5861,290
Other undisclosed current liabilities(15)(658)(8)(14)(17)(579) 
Total current liabilities:2,9153,2882,8052,6432,2252,6392,459
Noncurrent Liabilities
Long-term debt and lease obligation, including:4,0514,0354,0425,0155,0165,0185,063
Other undisclosed long-term debt and lease obligation4,0514,0354,0425,0155,0165,0185,063
Liabilities, other than long-term debt2,6902,7362,8342,6912,4432,4612,467
Accrued income taxes9749871,0971,1531,1361,1471,106
Deferred tax liabilities, net 679   605 
Restructuring reserve30332714141315
Other liabilities1,6861,0371,7101,5241,2936961,346
Other undisclosed noncurrent liabilities525522529536539558555
Total noncurrent liabilities:7,2667,2937,4058,2427,9988,0378,085
Total liabilities:10,18110,58110,21010,88510,22310,67610,544
Temporary equity, carrying amount62605960   
Stockholders' equity
Stockholders' equity attributable to parent10,37210,0609,9549,5629,3969,2429,671
Common stock91919090989797
Treasury stock, value(164)(139)(136)(136)(2,522)(2,210)(1,582)
Additional paid in capital7,9457,8427,8017,7287,6287,5497,490
Accumulated other comprehensive income31145288275280292229
Retained earnings2,4692,1211,9111,6053,9123,5143,437
Total stockholders' equity:10,37210,0609,9549,5629,3969,2429,671
TOTAL LIABILITIES AND EQUITY:20,61520,70120,22320,50719,61919,91820,215

Income statement (P&L) ($ in millions)

12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
3/31/2014
Q2
12/31/2013
Q1
9/30/2013
Q4
6/30/2013
Q3
Revenues
(Revenue, Net)
2,6862,7342,6882,5982,6392,5602,578
Cost of revenue
(Cost of Goods and Services Sold)
(1,042)(1,072)(1,104)(1,080)(1,076)(1,073)(1,045)
Gross profit:1,6441,6621,5841,5181,5631,4871,533
Operating expenses(1,061)(1,222)(1,304)(1,008)(1,113)(1,071)(1,046)
Other undisclosed operating income65738672815655
Operating income:648513366582531472542
Nonoperating income (expense)(24)(50)(26)4517158
Investment income, nonoperating33462 2
Foreign currency transaction gain (loss), before tax(7)13(16)(28)(18)  
Other nonoperating income (expense)(20)(66)(14)6733 56
Interest and debt expense(48)(49)(48)(54)(53)(73)(53)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes7(13)16281843 
Income from continuing operations before income taxes:583401308601513443547
Income tax expense (benefit)(72)116(2)(160)(115)(79)(147)
Net income:511517306441398364400
Other undisclosed net income (loss) attributable to parent     8(4)
Net income available to common stockholders, diluted:511517306441398372396

Comprehensive Income ($ in millions)

12/31/2014
Q1
9/30/2014
Q4
6/30/2014
Q3
3/31/2014
Q2
12/31/2013
Q1
9/30/2013
Q4
6/30/2013
Q3
Net income:511517306441398364400
Other comprehensive loss(114)      
Comprehensive income:397517306441398364400
Other undisclosed comprehensive income (loss), net of tax, attributable to parent (143)13(5)(12)70(25)
Comprehensive income, net of tax, attributable to parent:397374319436386434375

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: